相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AMOT suppresses tumor progression via regulating DNA damage response signaling in diffuse large B-cell lymphoma
Tan Sang et al.
CANCER GENE THERAPY (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Combination of CD47 and signal-regulatory protein-α constituting the don't eat me signal is a prognostic factor in diffuse large B-cell lymphoma
Ryo Kazama et al.
CANCER SCIENCE (2020)
Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies
Aung M. Tun et al.
CANCER TREATMENT REVIEWS (2020)
CD47 Overexpression Is Associated with Epstein-Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma
Zhi-Hui Wang et al.
ONCOTARGETS AND THERAPY (2020)
CD47: the next checkpoint target for cancer immunotherapy
Ridong Feng et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
Yang Liu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling
Juan Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
Xiangxiang Zhou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Role of CD47 in Hematological Malignancies
Entsar Eladl et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Cell Metabolomics Reveals Berberine-Inhibited Pancreatic Cancer Cell Viability and Metastasis by Regulating Citrate Metabolism
Jingjing Liu et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Low-Dose Berberine Attenuates the Anti-Breast Cancer Activity of Chemotherapeutic Agents via Induction of Autophagy and Antioxidation
Bing Han et al.
DOSE-RESPONSE (2020)
In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects
Wenyu Ma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
The functions and clinical significance of circRNAs in hematological malignancies
Xiangxiang Zhou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
Demet Candas-Green et al.
NATURE COMMUNICATIONS (2020)
Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Leonard Jeff Harris et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis
Tuo Hu et al.
THERANOSTICS (2020)
The Macrophage Do not eat me' signal, CD47, is a clinically validated cancer immunotherapy target
C. H. Takimoto et al.
ANNALS OF ONCOLOGY (2019)
A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine
Da Liu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
Christian M. Schurch et al.
THYROID (2019)
Tumor-infiltrating CD8+T cells combined with tumor-associated CD68+macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer
Jun Lu et al.
BMC CANCER (2019)
Inhibitory effect of berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells
Sindy Hu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation
Eric Hatterer et al.
MABS (2019)
Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway
Fa Jin et al.
PHARMACEUTICAL BIOLOGY (2019)
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng et al.
NATURE REVIEWS CANCER (2019)
CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis
Li-Chung Tsao et al.
JCI INSIGHT (2019)
Cell-specific pattern of berberine pleiotropic effects on different human cell lines
Alessandro Agnarelli et al.
SCIENTIFIC REPORTS (2018)
Diverse Functions of Macrophages in Different Tumor Microenvironments
Ming Yang et al.
CANCER RESEARCH (2018)
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
Ranjana Advani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma
Qian Hu et al.
FRONTIERS IN PHARMACOLOGY (2018)
Is CD47 an innate immune checkpoint for tumor evasion?
Xiaojuan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma
Xiangxiang Zhou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition
Dong Hou et al.
CELL DEATH & DISEASE (2017)
The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects
Lynh Nguyen et al.
GENES (2017)
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
Gilles Salles et al.
ADVANCES IN THERAPY (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
Kipp Weiskopf et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7/TAM cells
Chunjie Wen et al.
MOLECULAR MEDICINE REPORTS (2016)
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey et al.
SCIENCE (2016)
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
Kipp Weiskopf et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma
Meng Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
Xiaojuan Liu et al.
NATURE MEDICINE (2015)
Berberine Induces Senescence of Human Glioblastoma Cells by Downregulating the EGFR-MEK-ERK Signaling Pathway
Qiao Liu et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis
Yuhua Wang et al.
MOLECULAR THERAPY (2013)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
Elias Campo et al.
BLOOD (2011)
Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51
Qiao Liu et al.
PLOS ONE (2011)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
Inhibition of self engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
Richard K. Tsai et al.
JOURNAL OF CELL BIOLOGY (2008)
Efficacy of berberine in patients with type 2 diabetes mellitus
Jun Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Role of CD47 as a marker of self on red blood cells
PA Oldenborg et al.
SCIENCE (2000)
分享论文
